Company / Revenue per Share
LIPELLA PHARMACEUTICALS INC. Revenue per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.71
FY2024
5-year range
$0.05 / $0.71
FY2022-FY2024
Trend
+805.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +805% YoY in FY2024, a notable deviation from the 2-year average annual change of +435%.
Based on SEC 10-K filings.
0.71 in FY2024.
Improved from $0.05 to $0.71 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, revenue per share increased 805.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.71 | +805.5% |
| FY2023 | $0.08 | +64.4% |
| FY2022 | $0.05 | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026